September 28, 2019

Global Developments in Clinical Trial Transparency

By Darshan Kulkarni, PharmD, MS, Esq., The Kulkarni Law Firm, Philadelphia, PA; Reema Butala, Overland Park, KS; Dan Benau, PhD, University of the Sciences, Philadelphia, PA

In his keynote address in 2018, Scott Gottlieb, the Food and Drug Administration (FDA) Commissioner, announced new initiatives towards greater transparency of clinical trials and making trial data more readily available to the public.1 

Premium Content For:
  • Health Law Section
Join - Now